Evaluation of Cefixime-Loaded Chitosan Microspheres: Analysis of Dissolution Data Using DDSolver

被引:15
作者
Murtaza, Ghulam [1 ]
Ahmad, Mahmood [2 ]
Khan, Shujaat Ali [1 ]
Hussain, Izhar [1 ]
机构
[1] COMSATS Inst Informat Technol, Dept Pharmaceut Sci, Abbottabad 22060, Pakistan
[2] Islamia Univ Bahawalpur, Dept Pharm, Fac Pharm & Alternat Med, Bahawalpur, Pakistan
来源
DISSOLUTION TECHNOLOGIES | 2012年 / 19卷 / 02期
关键词
DRUG-DELIVERY; ETHYLCELLULOSE MICROPARTICLES; INTESTINAL DELIVERY; CROSS-LINKING; ALGINATE; NIMESULIDE; RELEASE; MICROENCAPSULATION; FORMULATION; VISCOSITY;
D O I
10.14227/DT190212P13
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objectives of this study were to fabricate cefixime-loaded chitosan microspheres with the ultimate goal of prolonging drug release and to analyze the influence of various process variables on the properties of microspheres such as mode of drug release. The cefixime-loaded chitosan microspheres were fabricated using a coacervation technique. Various process variables like volume of solvent for chitosan (glacial acetic acid), chitosan concentration, volume of phase separation agent (NaOH solution), and glutaraldehyde concentration were varied to fabricate nine different formulations. Dissolution data were evaluated using DDSolver, new software developed for the kinetic analysis of dissolution data. The microspheres were spherical, porous, and dark brown. They ranged in size from 253.13 +/- 8.4 to 369.1 +/- 13.7 mu m, and the incorporation efficiency varied from 29.9 +/- 32% to 49.3 +/- 4.5%. The F5 formulation with a drug/polymer ratio of 1:3 (w/w) was the most suitable in terms of incorporation efficiency (49.3 +/- 4.5%), flow characteristics (Hausner ratio = 1.4), and drug release properties. The drug release was sustained up to many hours. Fickian diffusion was the primary mode of drug release from all cefixime-loaded chitosan microsphere formulations. These results show that cefixime can be successfully microencapsulated into chitosan shells by coacervation, which is influenced significantly by formulation variables such as chitosan and glutaraldehyde concentration.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 26 条
[1]  
Aamir MN, 2010, J CHEM SOC PAKISTAN, V32, P180
[2]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[3]  
Alencastre Juliana Bucchi, 2006, Rev. Bras. Cienc. Farm., V42, P69, DOI 10.1590/S1516-93322006000100007
[4]  
Arora S.C., 2010, INT J DRUG DEV RES, V2, P404
[5]   A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery [J].
Chen, SC ;
Wu, YC ;
Mi, FL ;
Lin, YH ;
Yu, LC ;
Sung, HW .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (02) :285-300
[6]   Preparation of cross-linked chitosan microspheres by spray drying: Effect of cross-linking agent on the properties of spray dried microspheres [J].
Desai, KGH ;
Park, HJ .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (04) :377-395
[7]   Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications [J].
Dini, E ;
Alexandridou, S ;
Kiparissides, C .
JOURNAL OF MICROENCAPSULATION, 2003, 20 (03) :375-385
[8]   Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review [J].
George, Meera ;
Abraham, T. Emilia .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (01) :1-14
[9]  
Gohel MC, 2007, AAPS PHARMSCITECH, V8, pE63
[10]   The Evaluation of Eudragit Microcapsules Manufactured by Solvent Evaporation Using USP Apparatus 1 [J].
Khamanga, Sandile M. ;
Parfitt, Natalie ;
Nyamuzhiwa, Tsitsi ;
Haidula, Hendrina ;
Walker, Roderick B. .
DISSOLUTION TECHNOLOGIES, 2009, 16 (02) :15-22